Tipping-point transition from transient to persistent inflammation in pancreatic islets

Area of Science:

• Immunology
• Endocrinology
• Computational Biology

Background:

• Type 2 diabetes (T2D) is linked to elevated pro-inflammatory cytokine IL-1β.
• Low IL-1β levels transiently benefit insulin secretion and beta-cell proliferation, while prolonged exposure impairs function and causes cell death.
• The local regulation of these opposing IL-1β effects within single pancreatic islets remains unclear.

Purpose of the Study:

• To investigate the dual nature of IL-1β signaling within pancreatic islets.
• To determine if islet-level regulation can explain transient versus persistent IL-1β responses.
• To model the IL-1β regulatory network in pancreatic islets using a quantitative in silico approach.

Main Methods:

• Developed a quantitative in silico model of the IL-1β regulatory network in pancreatic islets.
• Analyzed the network's response to pro-inflammatory and metabolic cues.
• Identified key feedback mechanisms governing IL-1β dynamics.

Main Results:

• The IL-1β regulatory network can generate both transient and persistent IL-1β responses.
• A balance between fast positive feedback (IL-1R/IKK/NF-κB) and slow negative feedback (e.g., A20) determines the response mode.
• Large islets and those with high IL-1β-producing cell density are more susceptible to persistent inflammation.

Conclusions:

• The duality of IL-1β effects is likely regulated at the single islet level.
• Feedback mechanisms involving positive and negative regulation on different timescales explain IL-1β response modes.
• Model predictions offer testable hypotheses for experimental validation and potential clinical applications in T2D.